
Amlodipine
Amlodipine lowered blood pressure by about 12/6 mmHg more than placebo in the label's trials and, in large outcome trials, protected against heart attacks about as well as a thiazide diuretic and, as the base of a two-drug regimen, against strokes and deaths better than an atenolol-based regimen, although it allowed more heart failure than the diuretic. In people with coronary artery disease and normal blood pressure it reduced angina admissions and artery procedures, and in severe heart failure it neither helped nor harmed survival. Its best-known side effect is ankle swelling. For supplements and foods, interactions are few and mostly mild: grapefruit has little effect on it, calcium supplements have not been shown to change its effect, and celery products may add a little to its blood pressure lowering.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults (and children 6 to 17 with high blood pressure) who need blood pressure lowering or angina treatment, prescribed and monitored by a prescriber
Common dosing range
Set by your prescriber. The label starts adults at 5 mg once daily with a maximum of 10 mg once daily; small, frail or older adults and people with liver problems may start at 2.5 mg; children 6 to 17 take 2.5 to 5 mg once daily
When to expect effects
Builds over days because of its long half-life; the label says to wait 7 to 14 days between dose steps
Watch out for
Ankle and leg swelling is common and dose-related (about 11 percent at 10 mg). The label warns that angina can worsen, or a heart attack occur, after starting or raising the dose in people with severe narrowing of the heart arteries, and that low blood pressure is possible with severe aortic stenosis. It raises simvastatin levels, so the label caps simvastatin at 20 mg a day
What is it
Amlodipine is a prescription calcium channel blocker used to lower high blood pressure, to treat chronic stable angina and vasospastic (Prinzmetal's) angina, and, in people with coronary artery disease recently shown on an angiogram who do not have heart failure or an ejection fraction (pumping strength) below 40%, to lower the chance of hospital stays for angina and of procedures to reopen heart arteries. It comes as Norvasc and generic amlodipine besylate tablets, as Norliqva oral solution, and as Katerzia oral suspension (made with amlodipine benzoate). It is a dihydropyridine, the type of calcium channel blocker that acts mainly on blood vessels rather than on the heart's rhythm, and it is taken once a day.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
heart attacks and deaths in high blood pressure, compared with a diuretic Good Evidence | Same rate of heart attack or coronary death as chlorthalidone (relative risk 0.98); 38 percent more heart failure | Adults 55 and older with high blood pressure and other heart risk factors | Assessed over about 5 years |
strokes and deaths in high blood pressure, compared with an atenolol-based regimen Good Evidence | 23 percent fewer strokes and 11 percent fewer deaths than an atenolol-based regimen; main coronary outcome not significantly different | Adults with high blood pressure and several other heart risk factors | Assessed over a median of 5.5 years |
cardiovascular events in coronary artery disease with normal blood pressure Good Evidence | 31 percent fewer cardiovascular events, mainly angina admissions and revascularization | Adults with angiographically documented coronary artery disease, without heart failure or an ejection fraction below 40 percent | Assessed over 24 months |
survival in severe heart failure Good Evidence | No difference in deaths (PRAISE-2 hazard ratio 1.09) | Not applicable | Assessed over up to about 3 years |
heart attacks and deaths in high blood pressure, compared with a diuretic
- Effect
- Same rate of heart attack or coronary death as chlorthalidone (relative risk 0.98); 38 percent more heart failure
- Best fit
- Adults 55 and older with high blood pressure and other heart risk factors
- Time
- Assessed over about 5 years
strokes and deaths in high blood pressure, compared with an atenolol-based regimen
- Effect
- 23 percent fewer strokes and 11 percent fewer deaths than an atenolol-based regimen; main coronary outcome not significantly different
- Best fit
- Adults with high blood pressure and several other heart risk factors
- Time
- Assessed over a median of 5.5 years
cardiovascular events in coronary artery disease with normal blood pressure
- Effect
- 31 percent fewer cardiovascular events, mainly angina admissions and revascularization
- Best fit
- Adults with angiographically documented coronary artery disease, without heart failure or an ejection fraction below 40 percent
- Time
- Assessed over 24 months
survival in severe heart failure
- Effect
- No difference in deaths (PRAISE-2 hazard ratio 1.09)
- Best fit
- Not applicable
- Time
- Assessed over up to about 3 years
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
heart attacks and deaths in high blood pressure, compared with a diuretic
Disease adjunctALLHAT randomized 33,357 people aged 55 or older with high blood pressure and at least one other heart risk factor to chlorthalidone (a thiazide-type diuretic), amlodipine or lisinopril, and followed them for a mean of 4.9 years. Fatal coronary heart disease or nonfatal heart attack, the main outcome, was the same with amlodipine as with chlorthalidone (6-year rates 11.3 versus 11.5 percent, relative risk 0.98), and deaths from any cause did not differ. Heart failure was more common with amlodipine (10.2 versus 7.7 percent, relative risk 1.38). The authors concluded that thiazide-type diuretics should be preferred as the first step; amlodipine remains a standard alternative.
Bottom line: In a very large trial, amlodipine prevented heart attacks about as well as a diuretic but allowed more heart failure.
strokes and deaths in high blood pressure, compared with an atenolol-based regimen
Disease adjunctASCOT-BPLA randomized 19,257 people aged 40 to 79 with high blood pressure and at least three other heart risk factors to amlodipine (adding perindopril as needed) or atenolol (adding a thiazide and potassium as needed). The trial was stopped early after a median 5.5 years. The main outcome, nonfatal heart attack or fatal coronary disease, was not significantly lower (429 versus 474 events, hazard ratio 0.90), but strokes (327 versus 422, hazard ratio 0.77), total cardiovascular events (0.84) and deaths from any cause (738 versus 820, hazard ratio 0.89) were lower with the amlodipine-based regimen, and fewer people developed diabetes. Each arm could add a second drug (perindopril, or a thiazide plus potassium), so the result reflects the two regimens, not amlodipine alone.
Bottom line: An amlodipine-based regimen prevented more strokes and deaths than an atenolol-based one.
cardiovascular events in coronary artery disease with normal blood pressure
Disease adjunctCAMELOT randomized 1,991 people with coronary artery disease on an angiogram and a diastolic pressure below 100 mmHg (average starting pressure 129/78) to amlodipine 10 mg, enalapril 20 mg or placebo for 24 months. Cardiovascular events occurred in 16.6 percent on amlodipine versus 23.1 percent on placebo (hazard ratio 0.69). The label notes the difference came mostly from fewer hospital stays for angina and fewer artery-opening procedures; heart deaths, heart attacks, strokes and heart failure admissions did not differ significantly. This is the basis for the label's coronary artery disease indication.
Bottom line: In one trial, amlodipine cut angina admissions and artery procedures in coronary artery disease.
survival in severe heart failure
No benefit foundPRAISE randomized 1,153 people with severe chronic heart failure and an ejection fraction below 30 percent to amlodipine or placebo for 6 to 33 months on top of usual treatment. The combined risk of death and major cardiovascular hospital stays was 39 versus 42 percent (not significant), and deaths were 33 versus 38 percent (not significant). A subgroup with nonischemic cardiomyopathy seemed to benefit, so PRAISE-2 tested 1,654 such patients for a median 33 months: deaths were 278 on amlodipine versus 262 on placebo (hazard ratio 1.09), with more swelling and lung fluid on amlodipine. The reassuring part is that amlodipine did not raise deaths, unlike older calcium channel blockers in heart failure.
Bottom line: Amlodipine did not improve survival in severe heart failure, though it did not worsen it either.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose, usually 5 to 10 mg once daily. Report ankle swelling and chest pain, and have your pharmacist check statins, antifungals and transplant drugs.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Worsening angina or a heart attack after starting or increasing the dose, particularly in people with severe obstructive coronary artery disease
Symptomatic low blood pressure, particularly in people with severe aortic stenosis; because the effect builds gradually, sudden severe drops are unlikely
Slower clearance in severe liver impairment (half-life about 56 hours), so the label says to raise the dose slowly
Liver problems after marketing: jaundice and liver enzyme rises, mostly like cholestasis or hepatitis, sometimes severe enough for hospital care, with an uncertain causal link
In severe heart failure trials, more reports of lung fluid (pulmonary edema) on amlodipine than on placebo
Who should avoid it
- People with known sensitivity to amlodipine: contraindicated
- People with severe aortic stenosis or severe obstructive coronary artery disease need careful dosing and monitoring, per the label's warnings
- Children under 6: the label says its effect on blood pressure at this age is not known
Pregnancy & breastfeeding
Pregnancy: the label says the limited data from post-marketing reports are not enough to tell whether amlodipine raises the risk of major birth defects or miscarriage, and that poorly controlled high blood pressure in pregnancy carries risks for both mother and baby. In rats, high doses reduced litter size and increased deaths in the womb, and prolonged pregnancy and labor. Breastfeeding: a published study found amlodipine in human milk at an estimated median relative infant dose of 4.2 percent, no adverse effects on breastfed infants have been observed, and its effect on milk production is unknown. If you are pregnant, planning a pregnancy or breastfeeding, talk to your doctor.
Interactions
Amlodipine raises simvastatin levels: 10 mg of amlodipine with 80 mg of simvastatin increased simvastatin exposure by 77 percent, which raises the risk of statin muscle injury. The label says to limit simvastatin to 20 mg a day in people taking amlodipine; the label also says amlodipine did not change atorvastatin exposure. Make sure both prescribers know you take both.
Amlodipine can raise levels of these transplant drugs: trough cyclosporine rose about 40 percent in 11 kidney transplant patients, and tacrolimus exposure rose 2.5- to 4-fold in some volunteers and 3-fold in one transplant patient. The label recommends frequent blood-level checks and dose adjustment, so tell your transplant team before amlodipine is started or stopped.
In a 4-week randomized crossover trial in 52 people with high blood pressure, celery seed extract capsules (1.34 g a day) lowered 24-hour systolic pressure from 141.2 to 130.0 mmHg, with no change on placebo; celery juice itself has not been tested. Regular use could add to amlodipine's effect and push readings lower than intended. Check your home blood pressure, watch for dizziness on standing, and review it with your doctor or pharmacist.
These drugs slow amlodipine's breakdown: diltiazem 180 mg a day raised amlodipine exposure by 60 percent in older adults, and the label says strong blockers such as itraconazole and clarithromycin may raise it more. The label advises watching for low blood pressure and swelling and says a lower amlodipine dose may be needed. It also says blood pressure should be closely watched with drugs that speed up CYP3A.
Amlodipine blocks calcium channels in artery walls, but it does not change blood calcium, and no study has shown that calcium supplements weaken its effect. In the Women's Health Initiative trial of 36,282 postmenopausal women, 1,000 mg of calcium plus 400 IU of vitamin D3 daily for a median 7 years did not change blood pressure, including in women with high blood pressure, though the trial did not report results for amlodipine users separately. Usual calcium doses are unlikely to matter; tell your prescriber if your home readings rise after a change.
Grapefruit blocks CYP3A in the gut and raises levels of some other calcium channel blockers, but amlodipine is absorbed almost completely anyway. In 20 healthy men, daily grapefruit juice did not meaningfully change amlodipine's blood levels or its effect on blood pressure, and the Norvasc label says grapefruit juice has no impact on amlodipine exposure. Ordinary amounts are unlikely to matter; your pharmacist can check whether other medicines you take are affected by grapefruit.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (2)
+ calcium
lowAmlodipine blocks calcium channels in artery walls, but it does not lower blood calcium, and no study has shown that calcium supplements weaken its effect. In the Women's Health Initiative trial of 36,282 postmenopausal women, 1,000 mg of calcium plus 400 IU of vitamin D3 daily for a median of 7 years did not change blood pressure, including in women with high blood pressure, though the trial did not report results for amlodipine users separately. Any interaction is theoretical.
+ grapefruit
lowAbout 90 percent of amlodipine is broken down by the liver, and CYP3A blockers can raise its levels, but grapefruit juice does not meaningfully change it. In a randomized crossover study in 20 healthy men, daily grapefruit juice for 9 days left amlodipine's blood levels and its blood-pressure effect essentially unchanged, and the Norvasc label states that grapefruit juice has no impact on amlodipine exposure. This differs from other dihydropyridine calcium channel blockers such as felodipine, whose levels grapefruit raises substantially.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I eat grapefruit or drink grapefruit juice with amlodipine?⌄
For amlodipine itself, grapefruit has little effect: in a study of healthy men, daily grapefruit juice did not change amlodipine levels or blood pressure, and the label says grapefruit juice has no impact on amlodipine exposure. Grapefruit does affect many other medicines, so ask your pharmacist if you take anything else.
Do calcium supplements interfere with amlodipine?⌄
There is no good evidence that they do. Amlodipine blocks calcium channels in blood vessel walls, not calcium in your diet or blood, and a large trial found calcium plus vitamin D did not change blood pressure. If you take calcium for your bones, keep checking your home blood pressure and tell your prescriber if it rises.
Can celery juice or celery seed lower my blood pressure too much with amlodipine?⌄
It could add to the effect. A small trial found celery seed extract lowered blood pressure in people with high blood pressure; celery juice has not been tested. If you start a regular celery routine, check your home readings, watch for dizziness on standing, and tell your doctor or pharmacist.
Why are my ankles swollen on amlodipine?⌄
Ankle and leg swelling is the most common side effect and depends on the dose: about 11 percent of people on 10 mg had it in label trials, versus under 1 percent on placebo, and it was more common in women. Tell your prescriber, especially if you also have shortness of breath, because swelling can have other causes, including heart failure.
I take simvastatin. Is that a problem with amlodipine?⌄
It can be. Amlodipine raises simvastatin levels, and the label says to keep simvastatin at 20 mg a day or less when taking amlodipine, because higher statin levels raise the risk of muscle injury. Ask your prescriber or pharmacist to check your statin dose; do not change it yourself.
How long does amlodipine take to work?⌄
Its effect builds over several days because it stays in the body a long time (a half-life of 30 to 50 hours) and reaches a steady level after about 7 to 8 days. That is why the label suggests waiting 7 to 14 days between dose changes. Take it at about the same time each day as prescribed.
References by claim
heart attacks and deaths in high blood pressure, compared with a diuretic
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial et al., 2002 · PubMed (2002) link
strokes and deaths in high blood pressure, compared with an atenolol-based regimen
Dahlöf et al., 2005 · PubMed (2005) link
cardiovascular events in coronary artery disease with normal blood pressure
Nissen et al., 2004 · PubMed (2004) link
survival in severe heart failure
Safety
Norvasc (amlodipine besylate) tablets prescribing information · DailyMed (FDA label) link
Interaction: Celery juice and celery seed extract
Shayani Rad et al., 2022 · PubMed (2022) link
Interaction: Calcium supplements
Margolis et al., 2008 · PMC (2008) link
Interaction: Grapefruit and grapefruit juice
Vincent et al., 2000 · PMC (2000) link
Track Amlodipine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
